To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cas No.: |
| Cat. No. | Product name | Field of application |
| A1061 | Osemitamab Biosimilar(Anti-CLDN18.2 Reference Antibody) | Osemitamab is an IgG1 antibody targeting to human claudin-18.2. Osemitamab consists of human-Mus musculus monoclonal TST001 γ1-chain, disulfide with human-Mus musculus monoclonal TST001 κ-chain, dimer (ACI). Osemitamab in combination with Capecitabine (HY-B0016) and Oxaliplatin (HY-17371), can be used for G/GEJ cancer study. |
| A1060 | Muromonab Biosimilar（Anti-CD3 Reference Antibody） | Muromonab is a monoclonal antibody targeting the CD3 receptor. Muromonab can block all cytotoxic T cell function. Muromonab also as an immunosuppressant agent given to reduce acute solid organ transplant rejection. |
| A1059 | Atoltivimab Biosimilar（Anti-EBOV Reference Antibody） | Atoltivimab (REGN3470), or maftivimab/odesivimab (Inmazeb) is the first Food and agent Administration (FDA)-approved monoclonal antibody to target Zaire ebolavirus (EBOVs) infection. |
| A1058 | Navivumab Biosimilar（Anti-HA Reference Antibody） | Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2. |
| A1057 | Anti-IAV Reference Antibody Biosimilar | |
| A1056 | Odesivimab Biosimilar（Anti-Zaire Ebola virus Reference Antibody） | Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection. |
| A1055 | Cosfroviximab Biosimilar（Anti-Zaire Ebola virus Reference Antibody） | Cosfroviximab (c13C6-FR1) is a mouse/human chimeric monoclonal antibody against Ebola virus glycoprotein (EBOV-GP). |
| A1054 | Porgaviximab Biosimilar（Anti-Zaire Ebola virus Reference Antibody） | Porgaviximab is a monoclonal antibody that can be used Ebola infection research. |
| A1053 | Larcaviximab Biosimilar（Anti-Zaire Ebola virus Reference Antibody） | Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody. |
| A1052 | Romlusevimab Biosimilar（Anti-Spike RBD Reference Antibody） | Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). |